Hester Biosciences Limited (NSE:HESTERBIO) — Stock Price

Rs2493.80 INR
▲ 3.14% today

Hester Biosciences Limited (NSE:HESTERBIO) is currently trading at Rs2493.80 INR, up 3.14% today. Over the past 52 weeks, shares have ranged between Rs1259.10 and Rs2545.00. This page tracks Hester Biosciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Hester Biosciences Limited (HESTERBIO) market capitalisation.

Hester Biosciences Limited (HESTERBIO) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Hester Biosciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Hester Biosciences Limited Income Statement — Revenue, Profit & Earnings by Year

Hester Biosciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs3.11 Billion Rs3.05 Billion Rs2.66 Billion Rs2.35 Billion Rs2.14 Billion
Cost of Revenue Rs1.03 Billion Rs2.07 Billion Rs774.86 Million Rs688.55 Million Rs563.93 Million
Gross Profit Rs2.08 Billion Rs972.64 Million Rs1.89 Billion Rs1.66 Billion Rs1.58 Billion
Research & Development Rs59.52 Million Rs46.65 Million Rs33.94 Million — Rs10.24 Million
SG&A Rs650.76 Million Rs49.02 Million Rs53.23 Million Rs74.15 Million Rs59.57 Million
Total Operating Expenses Rs682.20 Million Rs593.04 Million Rs554.98 Million Rs419.85 Million Rs991.79 Million
Operating Income Rs455.05 Million Rs364.77 Million Rs310.27 Million Rs1.25 Billion Rs567.84 Million
EBITDA Rs649.76 Million Rs582.46 Million Rs619.20 Million Rs731.93 Million Rs700.21 Million
EBIT Rs481.74 Million Rs410.72 Million Rs412.25 Million Rs566.12 Million Rs567.07 Million
Interest Expense Rs127.03 Million Rs94.29 Million Rs54.80 Million Rs35.33 Million Rs66.04 Million
Income Before Tax Rs395.71 Million Rs319.53 Million Rs401.54 Million Rs535.02 Million Rs501.03 Million
Income Tax Expense Rs107.45 Million Rs107.87 Million Rs121.19 Million Rs140.18 Million Rs154.05 Million
Net Income Rs274.88 Million Rs188.89 Million Rs266.27 Million Rs393.20 Million Rs344.30 Million

Hester Biosciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Hester Biosciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs6.53 Billion Rs6.62 Billion Rs5.46 Billion Rs5.62 Billion Rs4.11 Billion
Total Current Assets Rs1.95 Billion Rs2.15 Billion Rs2.16 Billion Rs1.95 Billion Rs1.62 Billion
Cash & Equivalents — — — — Rs0.00
Short-term Investments Rs12.54 Million Rs25.56 Million Rs183.07 Million Rs4.53 Million Rs2.93 Million
Net Receivables Rs731.81 Million Rs786.45 Million Rs882.07 Million Rs631.23 Million Rs551.50 Million
Inventory Rs703.77 Million Rs755.81 Million Rs792.16 Million Rs753.82 Million Rs622.22 Million
Property, Plant & Equipment Rs4.09 Billion Rs4.08 Billion Rs4.05 Billion Rs3.17 Billion Rs2.41 Billion
Goodwill — — — — —
Total Liabilities Rs3.27 Billion Rs3.59 Billion Rs2.53 Billion Rs2.95 Billion Rs1.75 Billion
Total Current Liabilities Rs1.25 Billion Rs1.06 Billion Rs1.36 Billion Rs968.98 Million Rs613.66 Million
Long-term Debt Rs1.33 Billion Rs1.82 Billion Rs833.97 Million Rs1.65 Billion Rs828.42 Million
Net Debt Rs2.06 Billion Rs2.32 Billion Rs1.60 Billion Rs2.04 Billion Rs888.92 Million
Total Stockholder Equity Rs3.14 Billion Rs2.92 Billion Rs2.92 Billion Rs2.60 Billion Rs2.28 Billion
Retained Earnings Rs2.37 Billion Rs2.15 Billion Rs2.03 Billion Rs1.85 Billion Rs1.54 Billion

Hester Biosciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Hester Biosciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs645.11 Million Rs481.34 Million Rs235.96 Million Rs88.08 Million Rs580.53 Million
Capital Expenditures Rs205.91 Million Rs243.97 Million Rs777.62 Million Rs957.10 Million Rs407.42 Million
Free Cash Flow Rs439.20 Million Rs237.37 Million Rs-541.66 Million Rs-869.02 Million Rs173.11 Million
Investing Cash Flow Rs-190.03 Million Rs-226.54 Million Rs-769.99 Million Rs-1.17 Billion Rs-383.72 Million
Financing Cash Flow Rs-517.17 Million Rs-260.45 Million Rs417.58 Million Rs1.12 Billion Rs-182.19 Million
Dividends Paid Rs51.68 Million Rs68.05 Million Rs85.07 Million Rs85.07 Million Rs56.15 Million
Stock-Based Compensation — — — — —
Depreciation Rs168.02 Million Rs171.74 Million Rs206.95 Million Rs165.81 Million Rs133.14 Million
Change in Cash Rs-67.83 Million Rs-4.08 Million Rs-115.94 Million Rs34.81 Million Rs-22.62 Million

Hester Biosciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Hester Biosciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 07, 2026 — — —
Jan 28, 2026 — — —
Oct 27, 2025 — — —
Jul 31, 2025 — — —
May 08, 2025 — — —
Jan 31, 2025 — — —
Feb 07, 2020 9.09 12.65 -28.14%
Nov 06, 2019 10.22 12.59 -18.82%